about
Pharmacokinetics of intraperitoneal cisplatin and doxorubicin.Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agents.Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastasesIdentification of molecular determinants of tumor sensitivity and resistance to anticancer drugs.Glutathione transferases as targets for cancer therapy.Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.Sex-related differences in renal toxicodynamics in rodents.Metabolic effects of antiangiogenic drugs in tumors: therapeutic implications.Ethylene negatively regulates transcript abundance of ROP-GAP rheostat-encoding genes and affects apoplastic reactive oxygen species homeostasis in epicarps of cold stored apple fruits.The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasisA new nitrobenzoxadiazole-based GSTP1-1 inhibitor with a previously unheard of mechanism of action and high stability.Vanillin Analogues o-Vanillin and 2,4,6-Trihydroxybenzaldehyde Inhibit NFĸB Activation and Suppress Growth of A375 Human Melanoma.Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro.Synthesis and preliminary in vitro biological evaluation of 4-[(4-hydroxyphenyl)sulfanyl]but-3-en-2-one, a 4-mercaptophenol derivative designed as a novel bifunctional antimelanoma agent.Irreversible CYP3A inhibition accompanied by plasma protein-binding displacement: a comparative analysis in subjects with normal and impaired liver function.Virtual Cross-Linking of the Active Nemorubicin Metabolite PNU-159682 to Double-Stranded DNA.Carteolol, a non-conventional partial agonist of beta(1)-adrenoceptors, relaxes phenylephrine-constricted rat aorta through antagonism at alpha(1)-adrenoceptors.In vitro evidence that carteolol is a nonconventional partial agonist of guinea pig cardiac beta1-adrenoceptors: a comparison with xamoterol.Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes.Inhibition of Cytochrome P450 2C8-mediated Drug Metabolism by the Flavonoid DiosmetinEditorial [Hot Topic: Enzymes as Useful Tools and Potential Targets in Cancer Chemotherapy (Guest Editor: P. Ruzza and L. Quintieri)]Hyperthermic Isolated Perfusion With Low-Dose Tumor Necrosis Factor α and Doxorubicin for the Treatment of Limb-Threatening Soft Tissue SarcomasR-warfarin anticoagulant effectLKB1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and γ-irradiationSynthesis and characterisation of a new benzamide-containing nitrobenzoxadiazole as a GSTP1-1 inhibitor endowed with high stability to metabolic hydrolysis
P50
Q35563280-64DC09C9-56C2-4A01-86DD-D765A8444066Q36185346-C744EE00-9026-460D-8957-528EB6B17713Q36617600-437F6779-B271-4BA8-9C51-45274BB73B62Q36723504-3C515731-5B1C-4D06-A781-A4304E6D5024Q37524192-1399F7E6-425C-47C5-A856-28EEC26907A9Q37716013-0A761280-4247-4A07-8465-C6A05E6734C4Q38024404-1912DF0B-3BFF-47C1-9DD4-789B6EE8B8FDQ38194321-D26AF2C9-C726-4B2A-A169-803200C1626FQ38616452-97A2F131-5BE4-4683-BE44-AA32C6769E89Q38720370-2919B3F6-D888-4AA8-8727-18070A00CB71Q38720837-9F46E4F6-30A8-4673-9334-323D163686FBQ38735504-4EB7F9F1-0E47-4F49-A397-7BD94167BDD9Q42874591-72E3C981-1EDB-4A4D-B981-38F93469E934Q45929537-C5CD75C3-0934-4B89-94D3-B2568732CACEQ46237124-912A2DC3-45F8-4581-83ED-EF8E15C60AA8Q46435139-5CAEAFF9-683F-4687-B7FB-328101C5D67AQ46525405-1E99A3C5-9C23-4178-8E5C-24ED99C99604Q46701231-7DDD0FFD-6C18-47C0-9CF8-66982BDEB2BDQ46811435-0104CC75-E8A6-43E6-A7F3-270A58767F9FQ56979556-F0C3B173-BEDC-47AE-B3DE-DED5C4539B37Q58201410-DD9A7EA2-557E-4090-99AF-DC099F57C336Q58486156-5FF01F51-8A42-4B86-BCE3-5B3447C4B2BDQ88039068-0C0F4738-762C-4967-B974-096989D64DC0Q91484159-028ED82C-7415-4EC6-875E-AB4F6D3D1E6AQ92555460-541043E3-4A16-4925-A046-298CC1A17813
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Luigi Quintieri
@ast
Luigi Quintieri
@en
Luigi Quintieri
@es
Luigi Quintieri
@nl
type
label
Luigi Quintieri
@ast
Luigi Quintieri
@en
Luigi Quintieri
@es
Luigi Quintieri
@nl
prefLabel
Luigi Quintieri
@ast
Luigi Quintieri
@en
Luigi Quintieri
@es
Luigi Quintieri
@nl
P106
P1153
6602000759
P31
P496
0000-0001-7403-0921